Abstract
To evaluate the efficacy of cervical lidocaine gel in reducing patient discomfort during Pipelle endometrial sampling. From September 2012 to January 2013, 137 patients were evaluated with Pipelle endometrial biopsy. For group 1 (77 women), 2% lidocaine gel was applied to the cervical canal 3 min before endometrial sampling. For group 2 (60 women), a placebo gel was applied. The pain experienced by the patients during biopsy was evaluated using a 100 mm visual analog scale. The pain score was significantly lower during suction curettage (T3) in the group 1 than in the group 2. There was no significant difference between the groups in terms of pain score in other stages of the procedure (2.6±1.3 and 4.5±1.4; p=0.03). Cervical 2% lidocaine gel is simple and effective for decreasing pain associated with Pipelle endometrial biopsy.
Highlights
One-third of admissions to a gynecology clinic are because of abnormal uterine bleeding
This study aimed to investigate the effect of 2% lidocaine gel application to the cervical canal before Pipelle endometrial biopsy
There was no significant difference between the groups in terms of pain scores during the other stages
Summary
One-third of admissions to a gynecology clinic are because of abnormal uterine bleeding. Making a diagnosis, planning a treatment, and discriminating dysfunctional etiologies from organic ones are of great importance. Dysfunctional causes require medical treatment; organic causes such as myoma, polyp, or endometrial cancer require surgical treatment. One of the most important stages for the discrimination is the evaluation of the endometrium. Transvaginal ultrasonography is relatively useful as it enables the evaluation of the myometrium and adnexial pathologies together with the endometrium in women who have abnormal uterine bleeding. Its efficacy is limited in the evaluation of endometrial pathologies (sensitivity, 89.4%; specificity, 71.4%) [3, 4]. Dilatation and curettage (D&C), described by Recaimer in 1843, has been accepted as the gold standard in the diagnosis of endometrial pathologies [5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
